CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+8.51%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$7.52B
AUM Growth
+$7.52B
(+19%)
Cap. Flow
+$816M
Cap. Flow
% of AUM
10.85%
Top 10 Holdings %
Top 10 Hldgs %
19.11%
Holding
870
New
79
Increased
318
Reduced
279
Closed
56
Top Buys
| 1 |
Amgen
AMGN
|
$78.9M |
| 2 |
Biogen
BIIB
|
$72.5M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$63.8M |
| 4 |
Merck
MRK
|
$58M |
| 5 |
Gilead Sciences
GILD
|
$33.8M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$26.1M |
| 2 |
iRobot
IRBT
|
$15.5M |
| 3 |
Quest Diagnostics
DGX
|
$15.1M |
| 4 |
Colgate-Palmolive
CL
|
$14.9M |
| 5 |
Philip Morris
PM
|
$12.2M |
Sector Composition
| 1 | Healthcare | 33.27% |
| 2 | Technology | 16.05% |
| 3 | Financials | 11.26% |
| 4 | Consumer Discretionary | 7.98% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Coca-Cola
KO
$297B
| $18.1M | 0.24% |
392,643
+38,211
| +11% | +$1.76M |
|
102
Elevance Health
ELV
$72.4B
| $18M | 0.24% |
65,627
-15,501
| -19% | -$4.25M |
|
103
TJX Companies
TJX
$155B
| $17.6M | 0.23% |
156,750
+6,613
| +4% | +$741K |
|
104
Eli Lilly
LLY
$661B
| $17.4M | 0.23% |
162,081
-102,872
| -39% | -$11M |
|
|
ONC
105
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $17.3M | 0.23% |
100,300
+58,800
| +142% | +$10.1M |
|
106
Morgan Stanley
MS
$237B
| $17.1M | 0.23% |
366,749
+135,549
| +59% | +$6.31M |
|
107
3M
MMM
$81B
| $16.8M | 0.22% |
79,694
+9,051
| +13% | +$1.91M |
|
108
TAL Education Group
TAL
$6.34B
| $16.6M | 0.22% |
646,500
-363,800
| -36% | -$9.35M |
|
109
Bio-Techne
TECH
$8.3B
| $16.5M | 0.22% |
80,700
+30,100
| +59% | +$6.14M |
|
|
ATVI
110
DELISTED
Activision Blizzard Inc.
ATVI
| $16.5M | 0.22% |
197,913
+113,913
| +136% | +$9.48M |
|
|
111
Colgate-Palmolive
CL
$67.7B
| $16.4M | 0.22% |
244,767
-222,225
| -48% | -$14.9M |
|
|
RETA
112
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $16M | 0.21% |
195,200
+48,500
| +33% | +$3.97M |
|
113
Air Products & Chemicals
APD
$64.8B
| $15.9M | 0.21% |
95,289
+61,620
| +183% | +$10.3M |
|
114
DuPont de Nemours
DD
$31.6B
| $15.8M | 0.21% |
244,925
-10,518
| -4% | -$676K |
|
|
BHVN
115
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $15.7M | 0.21% |
417,299
+210,200
| +101% | +$7.89M |
|
116
Illinois Tool Works
ITW
$76.2B
| $15.3M | 0.2% |
108,629
+76,858
| +242% | +$10.8M |
|
117
PTC Therapeutics
PTCT
$4.41B
| $15.3M | 0.2% |
325,523
+169,523
| +109% | +$7.97M |
|
|
BLUE
118
DELISTED
bluebird bio
BLUE
| $15.1M | 0.2% |
103,600
+38,000
| +58% | +$5.55M |
|
119
CBRE Group
CBRE
$47.3B
| $15.1M | 0.2% |
342,223
-68,122
| -17% | -$3M |
|
120
Mastercard
MA
$536B
| $14.8M | 0.2% |
66,421
-51,594
| -44% | -$11.5M |
|
121
McDonald's
MCD
$226B
| $14.8M | 0.2% |
88,351
-2,360
| -3% | -$395K |
|
122
Becton Dickinson
BDX
$54.3B
| $14.7M | 0.2% |
56,218
+3,568
| +7% | +$931K |
|
123
Franklin Resources
BEN
$13.3B
| $14.5M | 0.19% |
476,764
+21,378
| +5% | +$650K |
|
124
Puma Biotechnology
PBYI
$258M
| $14.5M | 0.19% |
316,200
+211,200
| +201% | +$9.68M |
|
125
Monster Beverage
MNST
$62B
| $14.4M | 0.19% |
246,946
+13,784
| +6% | +$803K |
|